Clinical Trials Logo

Agoraphobia clinical trials

View clinical trials related to Agoraphobia.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04922502 Completed - Clinical trials for Generalized Anxiety Disorder

Parent-based Treatment for Youth With Anxiety and Obsessive-compulsive Disorder

Start date: July 1, 2021
Phase: Phase 2/Phase 3
Study type: Interventional

Anxiety and obsessive-compulsive disorders are the most common mental health disorders in childhood and adolescence. A parenting intervention for youth with anxiety, called Supportive Parenting of Anxious Childhood Emotions ("SPACE"), has been recently developed to help target anxiety in children. In this intervention, therapists meet individually with parents to help them reduce anxiety behaviors in their children and support adaptive behaviors in their children. The purpose for the proposed study is to demonstrate the treatment efficacy of SPACE compared to a low-contact, therapist-supported bibliotherapy version of this intervention.

NCT ID: NCT04681261 Completed - Covid19 Clinical Trials

Occupational Balance, Fear and Agoraphobia

OB
Start date: May 4, 2020
Phase:
Study type: Observational

This study was planned to investigate occupational balance, fear of Covid-19 and agoraphobia in adults during the Covid-19 pandemic.

NCT ID: NCT04568109 Completed - Clinical trials for Panic Disorder With Agoraphobia

Effect of Cognitive-behavior Therapy on Fear Responses to Body Symptoms in Patients With Panic Disorder

Start date: February 1, 2010
Phase: N/A
Study type: Interventional

The present study aims to investigate a potential mechanism of successful CBT for panic disorder, i.e., the reduction of excessive anxious apprehension and fear responses to panic-related body symptoms in the context of CBT treatment. In the present non-randomized interventional study, effects of cognitive behavior therapy on reported symptoms and fear responses to panic-related body symptoms are investigated. It is expected that symptom improvement during CBT is associated with a decrease in the activation of the brain's fear network to panic-related body symptoms.

NCT ID: NCT03925987 Completed - Clinical trials for Generalized Anxiety Disorder

Predicting Treatment Response to Exposure Therapy Using Carbon Dioxide

Start date: June 7, 2018
Phase: N/A
Study type: Interventional

Anxiety disorders affect over a quarter of the population, yet very little is known about the variables that predict treatment outcome. The planned study explores whether a patient's response to a physiological test involving inhalation of carbon dioxide predicts their response to exposure therapy.

NCT ID: NCT03785223 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity

Start date: April 20, 2019
Phase: Phase 4
Study type: Interventional

Other psychiatric disorders, including anxiety, often co-occur with adult ADHD; with 85% of ADHD patients having at least one other psychiatric condition. The presence of a co-occurring anxiety disorder has been associated with additive clinical effects, leading to more global impairment, poorer outcome, greater resistance to treatment and increased costs of illness. Stimulants are effective first-line treatments for adult ADHD patients, however the literature has mostly examined these treatments in pure ADHD populations (i.e. without other psychiatric disorders). Thus, there is little information to guide physicians in making treatment decisions for patients with ADHD and a co-occurring condition. This trial aims to evaluate the efficacy and safety of methylphenidate hydrochloride controlled release capsules (Foquest) in treating adults aged 18-65 years with DSM-5 ADHD with and without a co-occurring anxiety disorder.The study uses a 14-week, randomized, placebo-controlled, cross-over design.

NCT ID: NCT03684577 Completed - Agoraphobia Clinical Trials

Efficacy of Hypnotherapy for Agoraphobia

WIKI-A
Start date: November 1, 2018
Phase: N/A
Study type: Interventional

The purpose of the study is to compare the efficacy of Hypnotherapy for the treatment of Agoraphobia compared to a wait-list control group.

NCT ID: NCT03547180 Completed - Clinical trials for Panic Disorder With Agoraphobia

Mechanisms of Treatment Change in Panic Disorder and Agoraphobia

Start date: January 2004
Phase: N/A
Study type: Interventional

The primary goal of the present study is to identify mechanisms of therapeutic change of two theoretically contrasting therapeutic procedures: The first phase consists of comparing the outcome of the capnometry-assisted breathing therapy (BRT) with cognitive restructuring (CT). During the second phase participants of both interventions will undergo in-vivo exposure.

NCT ID: NCT03522844 Completed - Anxiety Disorders Clinical Trials

Treatments for Anxiety: Meditation and Escitalopram

TAME
Start date: June 18, 2018
Phase: Phase 4
Study type: Interventional

We propose the first randomized, controlled study to assess the comparative effectiveness of Mindfulness-Based Stress Reduction (MBSR) with a medication for anxiety disorders. We will use escitalopram, gold-standard SSRI treatment for patients with anxiety disorders, and will examine the comparative effectiveness of the two treatments on anxiety symptoms and other outcomes important to patients.

NCT ID: NCT03206437 Completed - Anxiety Disorders Clinical Trials

Effect of Mindfulness Meditation on Physiological Response to Unpredictable Stimuli

Start date: June 20, 2017
Phase: N/A
Study type: Interventional

This study will evaluate the effects of Mindfulness-Based Stress Reduction (MBSR) on physiological reactivity. This study will focus on individuals with anxiety who will participate in an 8-week MBSR class. The investigators will test participants' reactivity to both predictable and unpredictable stimuli before and after the class to understand the physiological changes that may occur after to the intervention. Secondary measures include psychometric instruments and a delay discounting task.

NCT ID: NCT03156556 Completed - Clinical trials for Major Depressive Disorder

Improving Access to the Treatment of Anxiety and Depression Among Young Adults

Start date: May 15, 2017
Phase: N/A
Study type: Interventional

Anxiety and depression represent the most common mental health problems. Unfortunately, only a minority of people in need will seek or access traditional mental health services. Access to traditional psychological care is even more challenging for linguistic minorities as well as for people living in rural areas and for young adults - a group that has the highest rate of anxiety and depression but the lowest rate of consulting traditional services.Telepsychotherapy can facilitate access to effective psychological care as done in Australia where the government has been offering an evidence-based 8-week online therapy program called the Wellbeing Course. This online course helps people manage worry, stress, anxiety and depression. It has been evaluated in several clinical trials and successfully implemented as an Australian national treatment service. Its transdiagnostic nature, and the fact that the guidance of a clinician is not required for an efficient and safe administration and maintenance of therapeutic gains make it not only a viable option, but also an easily accessible fist line intervention. More recently, findings from a feasibility study conducted by our research laboratory have supported the efficacy of a French-Canadian translation among French-speaking minorities in New-Brunswick. A version of the Wellbeing Course for young adults has been developed called the Mood Mechanic Course. Empirical support has been obtained. This study is a feasibility open trial, the first phase of a 3-phase research program designed to implement a French-Canadian translation of the Mood Mechanic Course in New Brunswick targeting groups for which access to traditional services has been most problematic: youth (18 to 25 years old), people living in rural areas and linguistic minorities. The course is an 8-week week program based on principles of cognitive behaviour therapy. It includes five online lessons, do-it-yourself exercises, case stories, and additional resources on different topic such as sleep hygiene. Twenty young adults will be recruited across New Brunswick among French-Canadian minority communities. Self-report measures assessing anxiety and depression will be administered pre/post treatment and at a 3-month follow-up. It is expected that the course will help overcome barriers in help seeking to improve the mental health of our communities.